{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:05:14Z","timestamp":1789221914339,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00795-025-00451-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:53:21Z","timestamp":1762772001000},"page":"93-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["THBS1 inhibition alleviates inflammatory response by inhibiting TGF-\u03b2 and NLRP3 inflammasome in experimental murine dry eye"],"prefix":"10.1007","volume":"59","author":[{"given":"Yuan","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"12","key":"451_CR1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/eye.2017.118","volume":"31","author":"J Than","year":"2017","unstructured":"Than J et al (2017) Fingerprick autologous blood: a novel treatment for dry eye syndrome. Eye (Lond) 31(12):1655\u20131663","journal-title":"Eye (Lond)"},{"issue":"2","key":"451_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"The definition and classification of dry eye disease","year":"2007","unstructured":"The definition and classification of dry eye disease (2007) report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5(2):75\u201392","journal-title":"Ocul Surf"},{"issue":"4","key":"451_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/ICU.0000000000000768","volume":"32","author":"R Mittal","year":"2021","unstructured":"Mittal R, Patel S, Galor A (2021) Alternative therapies for dry eye disease. Curr Opin Ophthalmol 32(4):348\u2013361","journal-title":"Curr Opin Ophthalmol"},{"issue":"11s","key":"451_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, de Paiva CS (2017) The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 124(11s):S4-s13","journal-title":"Ophthalmology"},{"key":"451_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052434","author":"M Labetoulle","year":"2022","unstructured":"Labetoulle M et al (2022) Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052434","journal-title":"Int J Mol Sci"},{"key":"451_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100842","author":"T Kojima","year":"2020","unstructured":"Kojima T et al (2020) Advances in the diagnosis and treatment of dry eye. Prog Retin Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100842","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"451_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L et al (2017) TFOS DEWS II management and therapy report. Ocul Surf 15(3):575\u2013628","journal-title":"Ocul Surf"},{"issue":"4","key":"451_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","volume":"40","author":"Y Wei","year":"2014","unstructured":"Wei Y, Asbell PA (2014) The core mechanism of dry eye disease is inflammation. Eye Contact Lens 40(4):248\u2013256","journal-title":"Eye Contact Lens"},{"issue":"1","key":"451_CR9","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/ICO.0b013e31817f4075","volume":"27","author":"SC Pflugfelder","year":"2008","unstructured":"Pflugfelder SC et al (2008) Epithelial-immune cell interaction in dry eye. Cornea 27(1):S9-11","journal-title":"Cornea"},{"issue":"2","key":"451_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1542-0124(12)70297-5","volume":"7","author":"SC Pflugfelder","year":"2009","unstructured":"Pflugfelder SC, Stern ME (2009) Immunoregulation on the ocular surface: 2nd Cullen symposium. Ocul Surf 7(2):67\u201377","journal-title":"Ocul Surf"},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jtos.2020.05.012","volume":"19","author":"S Aggarwal","year":"2021","unstructured":"Aggarwal S et al (2021) Correlation of corneal immune cell changes with clinical severity in dry eye disease: an in vivo confocal microscopy study. Ocul Surf 19:183\u2013189","journal-title":"Ocul Surf"},{"issue":"2","key":"451_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417\u2013426","journal-title":"Mol Cell"},{"key":"451_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ et al (2015) NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 6:262","journal-title":"Front Pharmacol"},{"issue":"6","key":"451_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6):821\u2013832","journal-title":"Cell"},{"key":"451_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310866","author":"D Zhuang","year":"2023","unstructured":"Zhuang D et al (2023) NLRP3 inflammasome as a potential therapeutic target in dry eye disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241310866","journal-title":"Int J Mol Sci"},{"key":"451_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112792","author":"B Park","year":"2019","unstructured":"Park B et al (2019) Polydatin inhibits NLRP3 inflammasome in dry eye disease by attenuating oxidative stress and inhibiting the NF-\u03baB pathway. Nutrients. https:\/\/doi.org\/10.3390\/nu11112792","journal-title":"Nutrients"},{"issue":"5","key":"451_CR17","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1083\/jcb.103.5.1635","volume":"103","author":"J Lawler","year":"1986","unstructured":"Lawler J, Hynes RO (1986) The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103(5):1635\u20131648","journal-title":"J Cell Biol"},{"issue":"4","key":"451_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/33.4.3884704","volume":"33","author":"TN Wight","year":"1985","unstructured":"Wight TN et al (1985) Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 33(4):295\u2013302","journal-title":"J Histochem Cytochem"},{"key":"451_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.638536","volume":"12","author":"LS Gutierrez","year":"2021","unstructured":"Gutierrez LS, Gutierrez J (2021) Thrombospondin 1 in metabolic diseases. Front Endocrinol (Lausanne) 12:638536","journal-title":"Front Endocrinol (Lausanne)"},{"key":"451_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/296069","volume":"2011","author":"Z Lopez-Dee","year":"2011","unstructured":"Lopez-Dee Z, Pidcock K, Gutierrez LS (2011) Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm 2011:296069","journal-title":"Mediators Inflamm"},{"issue":"4","key":"451_CR21","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1167\/iovs.05-1305","volume":"47","author":"E Sekiyama","year":"2006","unstructured":"Sekiyama E et al (2006) Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest Ophthalmol Vis Sci 47(4):1352\u20131358","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"451_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.exer.2011.06.018","volume":"93","author":"M Matsuba","year":"2011","unstructured":"Matsuba M, Hutcheon AE, Zieske JD (2011) Localization of thrombospondin-1 and myofibroblasts during corneal wound repair. Exp Eye Res 93(4):534\u2013540","journal-title":"Exp Eye Res"},{"issue":"4","key":"451_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jtos.2018.07.005","volume":"16","author":"X Tan","year":"2018","unstructured":"Tan X et al (2018) The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf 16(4):470\u2013477","journal-title":"Ocul Surf"},{"issue":"6","key":"451_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1189\/jlb.1012524","volume":"94","author":"NB Gandhi","year":"2013","unstructured":"Gandhi NB et al (2013) Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress. J Leukoc Biol 94(6):1293\u20131301","journal-title":"J Leukoc Biol"},{"issue":"7","key":"451_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","volume":"93","author":"SE Crawford","year":"1998","unstructured":"Crawford SE et al (1998) Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93(7):1159\u20131170","journal-title":"Cell"},{"issue":"7","key":"451_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jid.2019.01.011","volume":"139","author":"VS Atanasova","year":"2019","unstructured":"Atanasova VS et al (2019) Thrombospondin-1 is a major activator of TGF-\u03b2 signaling in recessive dystrophic epidermolysis bullosa fibroblasts. J Invest Dermatol 139(7):1497-1505.e5","journal-title":"J Invest Dermatol"},{"key":"451_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.00001","volume":"8","author":"K Zhang","year":"2020","unstructured":"Zhang K et al (2020) Contribution of TGF-beta-mediated NLRP3-HMGB1 activation to tubulointerstitial fibrosis in rat with angiotensin II-induced chronic kidney disease. Front Cell Dev Biol 8:1","journal-title":"Front Cell Dev Biol"},{"key":"451_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105962","volume":"176","author":"J Sun","year":"2022","unstructured":"Sun J et al (2022) USF2 knockdown downregulates THBS1 to inhibit the TGF-\u03b2 signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury. Pharmacol Res 176:105962","journal-title":"Pharmacol Res"},{"key":"451_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073465","author":"BC Gilger","year":"2022","unstructured":"Gilger BC, Hirsch ML (2022) Therapeutic applications of adeno-associated virus (AAV) gene transfer of HLA-G in the eye. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073465","journal-title":"Int J Mol Sci"},{"issue":"4","key":"451_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41401-020-0484-5","volume":"42","author":"FM Yang","year":"2021","unstructured":"Yang FM et al (2021) The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4\/NF-\u03baB\/NLRP3 signaling. Acta Pharmacol Sin 42(4):593\u2013603","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"451_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS et al (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15(3):539\u2013574","journal-title":"Ocul Surf"},{"issue":"4","key":"451_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"11","author":"C Baudouin","year":"2013","unstructured":"Baudouin C et al (2013) Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 11(4):246\u2013258","journal-title":"Ocul Surf"},{"key":"451_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/309723","volume":"2013","author":"S Ka\u0161telan","year":"2013","unstructured":"Ka\u0161telan S et al (2013) Diagnostic procedures and management of dry eye. BioMed Res Int 2013:309723","journal-title":"BioMed Res Int"},{"issue":"5","key":"451_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.oftal.2016.12.009","volume":"92","author":"J Benitez-Del-Castillo S\u00e1nchez","year":"2017","unstructured":"Benitez-Del-Castillo S\u00e1nchez J et al (2017) Determination of inmune response and inflammation mediators in tears: changes in dry eye and glaucoma as compared to healthy controls. Arch Soc Esp Oftalmol 92(5):210\u2013217","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"451_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C et al (2016) Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 100(3):300\u2013306","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"451_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","volume":"31","author":"S Barabino","year":"2012","unstructured":"Barabino S et al (2012) Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 31(3):271\u2013285","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"451_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Chauhan SK, Dana R (2012) Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol 130(1):90\u2013100","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"451_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/mi.2009.21","volume":"2","author":"SK Chauhan","year":"2009","unstructured":"Chauhan SK, Dana R (2009) Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol 2(4):375\u2013376","journal-title":"Mucosal Immunol"},{"key":"451_CR39","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12509","author":"Y Xie","year":"2021","unstructured":"Xie Y et al (2021) Role of thrombospondin-1 in sepsis-induced myocardial injury. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12509","journal-title":"Mol Med Rep"},{"issue":"5","key":"451_CR40","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s10753-017-0601-x","volume":"40","author":"T Xing","year":"2017","unstructured":"Xing T et al (2017) Thrombospondin-1 production regulates the inflammatory cytokine secretion in THP-1 cells through NF-\u03baB signaling pathway. Inflammation 40(5):1606\u20131621","journal-title":"Inflammation"},{"issue":"4","key":"451_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/09680519060120040701","volume":"12","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala FS et al (2006) NALP3: a key player in caspase-1 activation. J Endotoxin Res 12(4):251\u2013256","journal-title":"J Endotoxin Res"},{"key":"451_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/JIR.S141220","volume":"11","author":"M Groslambert","year":"2018","unstructured":"Groslambert M, Py BF (2018) Spotlight on the NLRP3 inflammasome pathway. J Inflamm Res 11:359\u2013374","journal-title":"J Inflamm Res"},{"issue":"7575","key":"451_CR43","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665","journal-title":"Nature"},{"key":"451_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb08307.x","volume":"856","author":"CA Dinarello","year":"1998","unstructured":"Dinarello CA (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 856:1\u201311","journal-title":"Ann N Y Acad Sci"},{"key":"451_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","volume":"125","author":"Q Zheng","year":"2014","unstructured":"Zheng Q et al (2014) Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp Eye Res 125:1\u20138","journal-title":"Exp Eye Res"},{"key":"451_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.exer.2015.02.013","volume":"134","author":"Q Zheng","year":"2015","unstructured":"Zheng Q et al (2015) Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients. Exp Eye Res 134:133\u2013140","journal-title":"Exp Eye Res"},{"issue":"5","key":"451_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126277","volume":"10","author":"L Niu","year":"2015","unstructured":"Niu L et al (2015) Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients. PLoS ONE 10(5):e0126277","journal-title":"PLoS ONE"},{"key":"451_CR48","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.2147\/JIR.S310116","volume":"14","author":"J Zhang","year":"2021","unstructured":"Zhang J et al (2021) Calcitriol alleviates hyperosmotic stress-induced corneal epithelial cell damage via inhibiting the NLRP3-ASC-Caspase-1-GSDMD pyroptosis pathway in dry eye disease. J Inflamm Res 14:2955\u20132962","journal-title":"J Inflamm Res"},{"issue":"1","key":"451_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000519458","volume":"65","author":"G Wang","year":"2022","unstructured":"Wang G et al (2022) Exosomes derived from mouse adipose-derived mesenchymal stem cells alleviate benzalkonium chloride-induced mouse dry eye model via inhibiting NLRP3 inflammasome. Ophthalmic Res 65(1):40\u201351","journal-title":"Ophthalmic Res"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-025-00451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-025-00451-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-025-00451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:01:55Z","timestamp":1780128115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-025-00451-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s00795-025-00451-1","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental protocol was approved by the experimental animal ethics committee of Wuhan Myhalic Biotechnology Co., Ltd. (approval number: HLK-202307472; approval date: July 27, 2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}